CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shandong Jincheng Pharmaceutical Group Co Ltd Company Snapshot
Shandong Jincheng Pharmaceutical Group Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Jincheng Pharmaceutical Group Co Ltd with three other companies in this sector in China: Shenzhen Hepalink Pharmaceutical Group Co Ltd (2017 sales of 2.67 billion Chinese Renmimbi [US$383.77 million] of which 100% was Pharmaceutical Manufacturing), Zhejiang Jianfeng Group Company Limited (2.83 billion Chinese Renmimbi [US$406.29 million] of which 45% was Cement/Construction Materials), and Hunan ER-KANG Pharmaceutical Co Ltd (2.83 billion Chinese Renmimbi [US$406.48 million] of which 88% was Manufacture of Medicines).

Sales Analysis. During the year ended December of 2017, sales at Shandong Jincheng Pharmaceutical Group Co Ltd were 2.79 billion Chinese Renmimbi (US$400.75 million). This is an increase of 96.3% versus 2016, when the company's sales were 1.42 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shandong Jincheng Pharmaceutical Group Co Ltd (and since 2012, sales have increased a total of 249%). Sales of Chemical Trade saw an increase that was more than double the company's growth rate: sales were up 261.3% in 2017, from 212.89 million Chinese Renmimbi to 769.19 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shandong Jincheng Pharmaceutical Group Co Ltd
  Stock Performance Chart for Shandong Jincheng Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 13.65
(Figures in Chinese Renmimbi)
1 Week -0.1%   13 Weeks 0.2%  
4 Weeks -5.3%   52 Weeks -29.9%  
 
Shandong Jincheng Pharmaceutical Group Co Ltd Key Data:
  Ticker: 300233 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 2,788,037,101
(Year Ending Jan 2018).
Employees: 2,776
  Currency: Chinese Renmimbi Market Cap: 5,366,528,049
  Fiscal Yr Ends: December Shares Outstanding: 393,152,238
  Share Type: Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.